Further findings show that the downregulation of CYLD reduces the apoptosis induced by tumor necrosis factor-α, while also leading to the degradation of the NF-κB inhibitor IκB-α, thereby enhancing NF-κB activity in HCC cells163. Here, NFKB1 is linked to hepatocellular carcinoma.